Latest News about BNTX
Recent news which mentions BNTX
Pfizer asks FDA to OK COVID vaccines for children under 5
February 01, 2022
From MarketWatch
Why BioNTech Stock Is Climbing Higher Today
February 01, 2022
From Motley Fool
Pfizer to seek FDA nod for vaccine for children as young as six months, and latest studies find omicron may not protect against future infection
February 01, 2022
Tickers
BNTX
Tags
BNTX
From MarketWatch
Could This Be A Potential New Weapon In The Fight Against COVID-19?
February 01, 2022
From Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Surge; Alphabet Earnings in Focus
February 01, 2022
From Benzinga
Pfizer may seek FDA’s OK for COVID vaccine for kids under 5 as soon as Tuesday: reports
January 31, 2022
From MarketWatch
Pfizer Could Seek COVID-19 Vaccine Emergency Approval For Children Under 5 This Week
January 31, 2022
From Benzinga
Monday's Melt-Up Leaves the Market Muddled
January 31, 2022
From Motley Fool
Novavax: The Fall of a Covid-19 Vaccine Star
January 31, 2022
From InvestorPlace
A Look Into Healthcare Sector Value Stocks
January 31, 2022
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
2 Stocks That Are Generating More Than 300% Sales Growth
January 30, 2022
From Motley Fool
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
3 Things About BioNTech That Smart Investors Know
January 29, 2022
From Motley Fool
Why Novavax Stock Surged 14% on Friday
January 28, 2022
From Motley Fool
Why Novavax Stock Is Sinking Again This Week
January 27, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
From MarketWatch
From Benzinga
Why Coronavirus Vaccine Stocks Topped the Market Today
January 26, 2022
From Motley Fool
2 Stocks to Buy No Matter What Happens in 2022
January 26, 2022
From Motley Fool
From InvestorPlace
From InvestorPlace
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
From MarketWatch
Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial
January 25, 2022
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
January 25, 2022
From Benzinga
Here's What to Look For in Pfizer's Upcoming Earnings Report
January 25, 2022
From Motley Fool
Why Vaccine Stocks Like Moderna and Novavax Tumbled (Again) Today
January 24, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
